Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis
Patent
1982-06-28
1983-08-09
Rosen, Sam
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
Having a known elemental analysis
A61K 3514
Patent
active
043978410
ABSTRACT:
A concentrate of blood coagulation Factor VIII:C is obtained in high yield by fractionation of blood plasma with a sequence of adsorption steps employing two different water-insoluble, cross-linked polyelectrolyte copolymers, each in the presence of exogenous heparin.
REFERENCES:
patent: Re29698 (1978-07-01), Fekete et al.
patent: 3555001 (1971-01-01), Wallis et al.
patent: 4157431 (1979-06-01), Fields et al.
patent: 4203891 (1980-05-01), Rock
patent: 4278594 (1981-07-01), Amrani
patent: 4289691 (1981-09-01), Rock et al.
patent: 4348315 (1982-09-01), Blomback
patent: 4361509 (1982-11-01), Zimmerman
A. J. Johnson et al., J. Lab. Clin. Med. 92(a), 194-210 (1978).
A. J. Johnson et al., Thromb. Diath. Haemorrh. 34, N2, 589 (1975).
Meyer Scott J.
Monsanto Company
Rosen Sam
Williams, Jr. James W.
LandOfFree
Production of blood coagulation factor VIII:C does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of blood coagulation factor VIII:C, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of blood coagulation factor VIII:C will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-586800